Camp4 Therapeutics (CAMP) EBITDA Margin (2023 - 2026)
Camp4 Therapeutics' (CAMP) quarterly EBITDA Margin came in at 1416.62% in Q1 2026, up 3245.0% year-on-year from 42.35% in Q1 2025, and up 87.76% quarter-over-quarter from 11575.86% in Q4 2025.
Camp4 Therapeutics (CAMP) EBITDA Margin (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has disclosed EBITDA Margin across 4 years of filings, most recently posting 1416.62% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 1416.62%, up 3245.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2193.72% (up 123489.0% YoY), and the FY2025 annual result was 2298.54%, up 564486.0% from the prior year.
- EBITDA Margin came in at 1416.62% for Q1 2026 at Camp4 Therapeutics, up from 11575.86% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 840.81% in Q2 2025 to a low of 11575.86% in Q4 2025.
- The 4-year median for EBITDA Margin is 1899.25% (2025), against an average of 3222.85%.
- Across the five-year window, EBITDA Margin tumbled 953921 bps in 2025 and soared 3245 bps in 2026, its largest moves.
- Camp4 Therapeutics' EBITDA Margin stood at 3341.71% in 2023, then soared by 39 bps to 2036.66% in 2024, then sank by 468 bps to 11575.86% in 2025, then surged by 88 bps to 1416.62% in 2026.
- The last three EBITDA Margin figures came in at 1416.62% (Q1 2026), 11575.86% (Q4 2025), and 1899.25% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | -1,416.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,416.62% |
| Dec 31, 2025 | -11,575.86% |
| Sep 30, 2025 | -1,899.25% |
| Jun 30, 2025 | -840.81% |
| Mar 31, 2025 | -1,449.07% |
| Dec 31, 2024 | -2,036.66% |
| Sep 30, 2023 | -3,341.71% |